Cardlytics, Inc.

CDLX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$72,673-$9,283-$13,282-$15,589
Dep. & Amort.$6,988$6,917$6,923$6,500
Deferred Tax$0$0$0$0
Stock-Based Comp.$6,422$7,501$8,694$8,673
Change in WC-$302-$285-$2,179-$4,846
Other Non-Cash$61,326-$3,625-$6,862$8,241
Operating Cash Flow$1,761$1,225-$6,706$2,979
Investing Activities
PP&E Inv.-$14$0$0-$123
Net Acquisitions$0$200$0$350
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$4,450-$4,858-$3,903-$4,313
Investing Cash Flow-$4,464-$4,658-$3,903-$4,086
Financing Activities
Debt Repay.$0$0$0-$12
Stock Issued$0$0$0$11
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$12-$2,059-$3,034-$201
Financing Cash Flow-$12-$2,059-$3,034-$202
Forex Effect-$69$191$95-$85
Net Chg. in Cash-$2,784-$5,301-$13,548-$1,394
Supplemental Information
Beg. Cash$46,745$52,046$65,594$66,988
End Cash$43,961$46,745$52,046$65,594
Free Cash Flow-$2,703$1,225-$6,706-$1,457
Cardlytics, Inc. (CDLX) Financial Statements & Key Stats | AlphaPilot